7th Jun 2005 09:57
Sinclair Pharma PLC07 June 2005 Sinclair Pharma plc ("Sinclair" or the "Company") Application has been made to the London Stock Exchange for the admission of1,339,267 new ordinary shares of 1p each fully paid, ranking pari passu with theexisting ordinary shares ("Ordinary Shares"), to trading on the AlternativeInvestment Market ("AIM"). These new Ordinary Shares were allotted as deferredconsideration under the terms of the Biosurface Pharma AB acquisition bySinclair in November 2002. Trading in the new Ordinary Shares is expected to commence on 9 June 2005. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma